TCS Share Price in Focus; Launches Agentic AI Platform for Drug Development

Tata Consultancy Services (TCS) has launched TCS ADD™ AgentHub, a new AI platform aimed at pharmaceutical companies, as per the exchange filings.  

The platform is designed to help companies use AI in drug development while keeping track of regulatory and audit requirements.  

Platform to Help Pharma Companies Use AI 

Pharmaceutical companies deal with large amounts of data and strict rules during drug development. TCS said these factors can make it difficult for companies to use AI across their research and development work. 

ADD™ AgentHub allows companies to create their own AI agent hub and use AI agents across different clinical workflows. The platform also includes defined roles, human oversight and audit features.  

AI Agents to Handle Different Tasks 

The platform can be used for several activities, including data entry, coding, review, literature analysis, study design, protocol digitisation and clinical data review. 

It also supports SDTM transformation and medical monitoring assistance. TCS said companies can add different AI agents depending on what they need.  

TCS Claims Up to 40% Efficiency Gain 

According to TCS, solutions using the platform have shown up to 40% efficiency gains in clinical data management. The company also reported up to 30% lower effort in building clinical studies and up to 30% cost savings in end-to-end safety case processing. 

AI-based safety agents can also reduce quality control work by as much as 50%, according to the company. 

Humans Will Continue to Make Key Decisions 

TCS said the platform follows a Human + AI Operating Model. Under this approach, AI agents work within existing business processes, while people remain responsible for governance and decision-making.  

Read More: IPO Alert: Muthoot Fincorp Files DRHP with SEBI to Raise Funds! 

TCS Share Price Performance 

As of August 17, 2026, at 1:52 PM, TCS share price was trading at ₹2,320.90 per share, reflecting a fall of 1.70% from the previous trading session. 

Conclusion 

TCS is adding another AI product to its portfolio with ADD™ AgentHub. The platform is focused specifically on drug development and drug safety, with AI being used for routine tasks while people continue to handle important decisions. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.